Approfondimenti generali
Epatocarcinoma, Linee Guida AIOM, 2019. [Apri]
Hepatocellular Carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. [Apri] A service of the U.S. National Institutes of Health [Apri]
Referenze bibliografiche specifiche
Alsina A, et al. Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma. Liver Cancer. 2020;9(1):93-104 [Apri]
Briggs A, et al. Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma. Br J Cancer. 2020;122(12):1754-1759. [Apri]